✦ LIBER ✦

The Metabolism of 3-[(5-methyl-5H-as-triazino[5,6-b]-indol-3-yl)amino]-1-propanol (SK & F 21687): A Potent Antiviral

✍ Scribed by Dicuollo, C. John; Zarembo, J. E.; Pagano, Joseph F.

Book ID: 118016224
Publisher: Informa plc
Year: 1973
Tongue: English
Weight: 440 KB
Volume: 3
Category: Article
ISSN: 0049-8254
DOI: 10.3109/00498257309151511

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of (( S )-5-(Methoxymethyl)-7-

Discovery of (( S )-5-(Methoxymethyl)-7-(1-methyl-1 H -indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5- a ]pyrimidin-6-yl)(( S )-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I Kur Inhibitor

✍ Finlay, Heather J.; Lloyd, John; Vaccaro, Wayne; Kover, Alexander; Yan, Lin; Bha 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 465 KB

Correction to Discovery of (( S )-5-(Met

Correction to Discovery of (( S )-5-(Methoxymethyl)-7-(1-methyl-1 H -indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5- a ]pyrimidin-6-yl)(( S )-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I Kur Inhibitor

✍ Finlay, Heather J.; Lloyd, John; Vaccaro, Wayne; Kover, Alexander; Yan, Lin; Bha 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 108 KB

Discovery of N-[2-[5-[Amino(imino)methyl

Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa1

✍ Phillips, Gary B.; Buckman, Brad O.; Davey, David D.; Eagen, Keith A.; Guilford, 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 178 KB

ChemInform Abstract: Discovery of N-[2-[

ChemInform Abstract: Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6- [3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl] -N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa.

✍ M. M. MORRISSEY; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

Chemical Modification of DNA with Muta-C

Chemical Modification of DNA with Muta-Carcinogens. I. 3-Amino-1-methyl-5H-pyrido[4,3-b]indole and 2-Amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole: Metabolic Activation and Structure of the DNA Adducts

✍ Yuichi Hashimoto and Koichi Shudo 📂 Article 📅 1985 🏛 Environmental Health Information Service 🌐 English ⚖ 277 KB

Fundamentals of Early Clinical Drug Deve

Fundamentals of Early Clinical Drug Development (From Synthesis Design to Formulation) || Development and Scale-Up of a Heterocyclic Cross-Coupling for the Synthesis of 5-[2-(3-Methyl-3 H -imidazol-4-yl)-thieno[3,2- b ]pyridine-7-yl] amino-2-methyl-1 H -indole

✍ Abdel-Magid, Ahmed F.; Caron, Stéphane 📂 Article 📅 2006 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 376 KB

Using Recent Examples And Important Case Studies, The Fundamentals Of Early Clinical Drug Development: From Synthesis Design To Formulation Demonstrates The Central Role℗¡that Organic Synthesis Plays In The Early Clinical Evaluation Of Potential Drug Candidates. Reflections On Process Research Ii /